Nevo sirolimus-eluting coronary stent: Additional pivotal trial data

Additional data from the international, pivotal NEVO RES I trial in 394 patients showed that at 12 months, there were no episodes of stent thrombosis in the Nevo arm vs. 2 events in the Taxus Liberte arm, plus a third event at 13 months. There have also been no cases of cardiac death or out-of-hospital myocardial infarction (MI) in patients receiving Nevo. ...